sts graph function (STATA Corporation)
STATA Corporation is a verified supplier 
90
Structured Review
STATA Corporation
sts graph function
Sts Graph Function, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sts+graph+function/sts+graph+command/pmc09374480-150-6-5
Average 90 stars, based on 1 article reviews
Sts Graph Function, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sts+graph+function/sts+graph+command/pmc09374480-150-6-5
Average 90 stars, based on 1 article reviews
sts graph function - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Development of prognostic models for survival and care status in sporadic Creutzfeldt-Jakob disease Article Snippet: Survival was plotted using the Generated:Article Title: Predicting onset of secondary-progressive multiple sclerosis using genetic and non-genetic factors. Article Snippet: Background Predicting the transition from relapsing–remitting (RR) to secondary-progressive (SP) multiple sclerosis (MS) from early in the disease course is challenging.. Objective To construct prediction models for SPMS using sociodemographic and self-reported clinical measures that would be available at/near MS onset, with specific considerations for MS genetic risk factors.. Methods We conducted a retrospective cross-sectional study based on 1295 white, non-Hispanic individuals. Construct:Article Title: Predicting onset of secondary-progressive multiple sclerosis using genetic and non-genetic factors. Article Snippet: Background Predicting the transition from relapsing–remitting (RR) to secondary-progressive (SP) multiple sclerosis (MS) from early in the disease course is challenging.. Objective To construct prediction models for SPMS using sociodemographic and self-reported clinical measures that would be available at/near MS onset, with specific considerations for MS genetic risk factors.. Methods We conducted a retrospective cross-sectional study based on 1295 white, non-Hispanic individuals. |